These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 10599374)
1. Antibiotic resistance in bacteria. A current and future problem. Liu HH Adv Exp Med Biol; 1999; 455():387-96. PubMed ID: 10599374 [TBL] [Abstract][Full Text] [Related]
2. Current challenges in antibiotic resistance. Hand WL Adolesc Med; 2000 Jun; 11(2):427-38. PubMed ID: 10916132 [TBL] [Abstract][Full Text] [Related]
3. Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management. Fraimow HS; Abrutyn E Infect Dis Clin North Am; 1995 Sep; 9(3):497-530. PubMed ID: 7490430 [TBL] [Abstract][Full Text] [Related]
4. Problems and dilemmas of antimicrobial resistance. Murray BE Pharmacotherapy; 1992; 12(6 Pt 2):86S-93S. PubMed ID: 1480504 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus. Cunha BA Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442 [TBL] [Abstract][Full Text] [Related]
6. Current perspectives on multidrug-resistant bacteria. Epidemiology and control. Segal-Maurer S; Urban C; Rahal JJ Infect Dis Clin North Am; 1996 Dec; 10(4):939-57. PubMed ID: 8958176 [TBL] [Abstract][Full Text] [Related]
9. [Update on antibiotic resistance in Gram-positive bacteria]. Lozano C; Torres C Enferm Infecc Microbiol Clin; 2017 Jan; 35 Suppl 1():2-8. PubMed ID: 28129816 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action of newer antibiotics for Gram-positive pathogens. Hancock RE Lancet Infect Dis; 2005 Apr; 5(4):209-18. PubMed ID: 15792738 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance among clinically important gram-positive bacteria in the UK. Johnson AP J Hosp Infect; 1998 Sep; 40(1):17-26. PubMed ID: 9777517 [TBL] [Abstract][Full Text] [Related]
12. [Development of antibiotic resistance]. Bornkessel B Med Monatsschr Pharm; 1997 Sep; 20(9):245-7. PubMed ID: 9379996 [No Abstract] [Full Text] [Related]
13. Antimicrobial-resistant pathogens in the 1990s. Jacoby GA Annu Rev Med; 1996; 47():169-79. PubMed ID: 8712771 [TBL] [Abstract][Full Text] [Related]
14. Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011. Morrissey I; Seifert H; Canton R; Nordmann P; Stefani S; Macgowan A; Janes R; Knight D; J Antimicrob Chemother; 2013 Jan; 68(1):164-7. PubMed ID: 22941898 [TBL] [Abstract][Full Text] [Related]
15. [Changes of infections due to drug resistant bacteria and its control]. Yamaguchi K; Ohno A Nihon Rinsho; 2001 Apr; 59(4):639-44. PubMed ID: 11304983 [TBL] [Abstract][Full Text] [Related]
16. Gram-positive bacterial resistance. A challenge for the next millennium. Bassetti M; Melica G; Cenderello G; Rosso R; Di Biagio A; Bassetti D Panminerva Med; 2002 Sep; 44(3):179-84. PubMed ID: 12094131 [TBL] [Abstract][Full Text] [Related]
17. [Gram-positive bacterial infections resistant to antibiotic treatment]. Utili R Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629 [TBL] [Abstract][Full Text] [Related]
18. Bacterial resistance to antimicrobial agents: an overview from Korea. Kim WJ; Park SC Yonsei Med J; 1998 Dec; 39(6):488-94. PubMed ID: 10097674 [TBL] [Abstract][Full Text] [Related]